A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease
Clinical trial NCT05670782 · UNKNOWN
Trial details
- NCT number
- NCT05670782
- Sponsor
- FAScinate Therapeutics Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-19
- Primary completion
- 2025-10-30
- Enrollment
- 314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.